Author's reply to: Could cross-immunological reactivity to Trypanosoma cruzi antigens be considered a rational strategy for designing vaccines against cancer?

Eduardo Osinaga; Teresa Freire; Luis Ubillos

doi:10.1002/ijc.30246

Article Dans Une Revue International Journal of Cancer Année : 2016

Author's reply to: Could cross-immunological reactivity to Trypanosoma cruzi antigens be considered a rational strategy for designing vaccines against cancer?

(1, 2) , (1, 2) , (2)

1
2

Eduardo Osinaga

Fonction : Auteur

Institut Pasteur de Montevideo

Departamento de inmunobiologia

Teresa Freire

Fonction : Auteur

Institut Pasteur de Montevideo

Departamento de inmunobiologia

Luis Ubillos

Fonction : Auteur

Departamento de inmunobiologia

Domaines

Sciences du Vivant [q-bio]

Mariella Botta : Connectez-vous pour contacter le contributeur

https://riip.hal.science/pasteur-01499032

Soumis le : jeudi 30 mars 2017-20:20:24

Dernière modification le : mardi 18 janvier 2022-14:50:08

Dates et versions

pasteur-01499032 , version 1 (30-03-2017)

Identifiants

HAL Id : pasteur-01499032 , version 1
DOI : 10.1002/ijc.30246
PUBMED : 27352000

Citer

Eduardo Osinaga, Teresa Freire, Luis Ubillos. Author's reply to: Could cross-immunological reactivity to Trypanosoma cruzi antigens be considered a rational strategy for designing vaccines against cancer?. International Journal of Cancer, 2016, 139 (9), pp.2144. ⟨10.1002/ijc.30246⟩. ⟨pasteur-01499032⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

RIIP RIIP_MONTEVIDEO

17 Consultations

0 Téléchargements

Author's reply to: Could cross-immunological reactivity to Trypanosoma cruzi antigens be considered a rational strategy for designing vaccines against cancer?

Domaines

Dates et versions

Identifiants

Citer

Exporter

Collections

Altmetric

Partager